Correlation Between ProKidney Corp and Enzon Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both ProKidney Corp and Enzon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ProKidney Corp and Enzon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ProKidney Corp and Enzon Pharmaceuticals, you can compare the effects of market volatilities on ProKidney Corp and Enzon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ProKidney Corp with a short position of Enzon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ProKidney Corp and Enzon Pharmaceuticals.
Diversification Opportunities for ProKidney Corp and Enzon Pharmaceuticals
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between ProKidney and Enzon is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding ProKidney Corp and Enzon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enzon Pharmaceuticals and ProKidney Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ProKidney Corp are associated (or correlated) with Enzon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enzon Pharmaceuticals has no effect on the direction of ProKidney Corp i.e., ProKidney Corp and Enzon Pharmaceuticals go up and down completely randomly.
Pair Corralation between ProKidney Corp and Enzon Pharmaceuticals
If you would invest 179.00 in ProKidney Corp on August 29, 2024 and sell it today you would earn a total of 9.00 from holding ProKidney Corp or generate 5.03% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 4.35% |
| Values | Daily Returns |
ProKidney Corp vs. Enzon Pharmaceuticals
Performance |
| Timeline |
| ProKidney Corp |
| Enzon Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
ProKidney Corp and Enzon Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ProKidney Corp and Enzon Pharmaceuticals
The main advantage of trading using opposite ProKidney Corp and Enzon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ProKidney Corp position performs unexpectedly, Enzon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enzon Pharmaceuticals will offset losses from the drop in Enzon Pharmaceuticals' long position.| ProKidney Corp vs. Relay Therapeutics | ProKidney Corp vs. Stoke Therapeutics | ProKidney Corp vs. Pliant Therapeutics | ProKidney Corp vs. Black Diamond Therapeutics |
| Enzon Pharmaceuticals vs. Pmv Pharmaceuticals | Enzon Pharmaceuticals vs. NewAmsterdam Pharma | Enzon Pharmaceuticals vs. Tempest Therapeutics | Enzon Pharmaceuticals vs. IO Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |